ebola
gp
viral
protein
express
viru
surfac
mediat
entri
target
cell
howev
sever
studi
report
gp
express
also
caus
cell
round
cytotox
although
underli
mechan
remain
unknown
instanc
express
ebola
gp
marburg
gp
report
caus
cell
detach
without
death
addit
ebola
gp
zair
sudan
ivori
coast
subtyp
shown
caus
cell
round
detach
ascrib
downregul
mhc
class
cell
surfac
adhes
protein
interestingli
ebola
gp
reston
subtyp
believ
nonpathogen
human
less
sever
cell
round
effect
gp
also
believ
key
determin
viral
pathogenesi
viruslik
particl
vlp
contain
gp
shown
activ
human
endotheli
cell
macrophag
importantli
mucinlik
region
specif
shown
induc
cytotox
gp
express
similar
level
seen
ebola
viru
infect
addit
viru
protein
test
cytotox
collect
report
indic
ebola
gp
impart
cell
round
cytotox
addit
facilit
viral
entri
howev
separ
work
report
ebola
zair
gp
cytotox
express
isol
similar
level
seen
earli
viru
infect
anoth
studi
show
gp
detect
cell
infect
ebola
zair
viru
failur
detect
gp
infect
may
aris
gp
releas
infect
cell
either
solubl
glycoprotein
sgp
solubl
form
fulllength
gp
sgp
shown
caus
cytotox
suggest
releas
sgp
ebola
viru
infect
could
mechan
use
viru
prevent
cytotox
replic
spread
throughout
bodi
moreov
releas
sgp
may
also
explain
ebola
zair
gp
express
level
similar
earli
infect
cytotox
previou
studi
suggest
ebola
gp
incorpor
vlp
along
viral
np
protein
coexpress
cell
major
matrix
protein
ebola
drive
format
filament
vlp
resembl
wildtyp
ebola
viru
morpholog
play
import
role
viral
replic
assembl
bud
interact
cellular
factor
ubiquitin
ligas
compris
part
escrti
complex
compon
copii
complex
also
rna
bind
oligomer
properti
ebola
np
princip
compon
ribonucleocapsid
enclos
rna
phosphoryl
major
studi
suggest
critic
role
ebola
gp
caus
cytotox
gp
interact
np
form
viral
particl
therefor
investig
cellular
local
gp
np
transient
express
cell
sinc
ebola
gp
induc
cell
round
detach
hour
transfect
cellular
local
ebola
gp
examin
hour
transient
transfect
tri
gain
insight
mechan
gp
cytotox
end
cell
transient
transfect
hour
use
calcium
phosphat
transfect
method
variou
plasmid
compar
wildtyp
gp
local
fulllength
ebola
zair
gp
transfect
local
rel
cellular
er
golgi
examin
transfect
gp
peyfpgolgi
clontech
gp
np
local
express
vari
combin
examin
transfect
gp
np
plasmid
np
plasmid
alon
cell
fix
hour
posttransfect
stain
stain
includ
hoechst
dna
stain
antibodi
target
nuclear
pore
complex
npc
protein
earli
late
endosom
gp
stain
neutral
human
monoclon
antibodi
label
zenon
label
kit
molecular
probe
cell
imag
use
deltavis
microscop
subsequ
deconvolut
previous
describ
fulllength
ebola
gp
local
close
proxim
nuclear
membran
figur
howev
npc
stain
show
littl
overlap
gp
suggest
gp
local
nuclear
membran
thu
hypothes
gp
may
local
within
er
coexpress
ebola
gp
show
gp
local
within
er
figur
notabl
gp
found
within
late
endosom
figur
golgi
earli
endosom
data
shown
sinc
fulllength
gp
local
within
er
close
proxim
nuclear
membran
examin
whether
gp
lack
mucinlik
region
cytotox
activ
also
local
er
strikingli
express
compar
level
fulllength
gp
accumul
er
figur
instead
uniformli
express
throughout
cell
local
within
golgi
earli
endosom
figur
late
endosom
figur
either
dispers
local
suggest
diffus
local
plasma
membran
coexpress
gp
alter
local
either
protein
gp
remain
close
proxim
nuclear
membran
consist
er
local
local
near
plasma
membran
figur
agre
previou
report
howev
separ
studi
show
ebola
gp
local
plasma
membran
either
tissu
experiment
infect
nonhuman
primat
hela
cell
hour
posttransfect
addit
gp
report
local
within
filament
structur
follow
gp
coexpress
suggest
gp
interact
morphogenesi
observ
littl
overlay
gp
gp
must
associ
filament
produc
infecti
virion
perhap
later
phase
viral
replic
cycl
therefor
earli
hour
timepoint
like
gp
amount
associ
filament
structur
limit
compar
total
cellular
amount
gp
make
difficult
visual
fluoresc
microscopi
ebola
np
express
isol
accumul
larg
cytoplasm
aggreg
figur
stain
intermedi
filament
protein
vimentin
reveal
np
aggreg
line
vimentin
aggresom
perinuclear
structur
line
vimentin
recruit
molecular
chaperon
proteosom
believ
regul
protein
fold
degrad
misfold
protein
therefor
np
associ
vimentin
suggest
np
present
aggresomelik
structur
previou
studi
use
cell
infect
marburg
viru
report
marburg
np
accumul
structur
resembl
inclus
bodi
close
proxim
er
possibl
ebola
np
aggresomelik
structur
could
perhap
serv
site
assembl
filovir
nucleocapsid
analog
african
swine
fever
viru
herp
simplex
viru
type
np
coloc
upon
coexpress
figur
seen
filament
structur
near
plasma
membran
np
local
within
distinct
cytoplasm
aggresomelik
bodi
actin
stain
also
show
littl
overlay
either
np
figur
correl
report
actin
incorpor
vlp
contain
gp
alon
detect
np
filament
structur
previou
studi
suggest
np
interact
directli
present
vlp
np
coexpress
thu
perhap
np
recruit
vlp
later
stage
filament
format
hour
experi
anoth
viral
protein
requir
np
interact
filovir
replic
take
place
cytoplasm
intrigu
fulllength
gp
accumul
er
close
proxim
nuclear
membran
hour
transient
express
cell
suggest
fulllength
gp
local
er
could
play
role
cytotox
cell
round
properti
mucinlik
region
gp
report
caus
cytotox
accumul
gp
er
might
induc
cytotox
effect
remain
defin
gp
mucinlik
region
activ
signal
pathway
also
downregul
activ
mapk
effector
link
gp
induc
cytotox
recent
classic
swine
fever
viru
protein
report
local
er
caus
er
stress
activ
similarli
sar
coronaviru
protein
caus
er
stress
activ
perk
pathway
lead
unfold
protein
respons
upr
therefor
ebola
gp
accumul
er
may
interfer
protein
synthesi
fold
transport
therebi
activ
upr
caus
er
stress
understand
exact
mechan
gp
accumul
er
correl
cytotox
may
use
design
inhibitor
block
cytotox
effect
ebola
viru
infect
patient
andor
potenti
reduc
sever
pathogen
effect
patient
experi
ebgp
ebola
viru
glycoprotein
er
endoplasm
reticulum
mitogen
respons
extracellular
regul
kinas
surfac
subunit
gp
gp
mucinlik
region
delet
mapk
mitogen
activ
protein
kinas
np
nucleoprotein
npc
nuclear
pore
complex
perk
prkrlike
er
kinas
sgp
solubl
glycoprotein
upr
unfold
protein
respons
vlp
viruslik
particl
author
declar
compet
interest
sb
tjh
conceiv
design
studi
sb
perform
experi
sb
tjh
interpret
result
wrote
manuscript
author
read
approv
final
manuscript
